Answers are grounded in this paper and cite their sources.
The process of reversible protein glutathionylation is now well established but these findings need to be substantiated at the tissue and organ levels, and also with disease state. That being said, irreversible protein glutathionylation can also occur and this has implications in disease and aging. Toxicologists should consider this when evaluating the possible side effects of certain drugs such as busulfan that may generate a glutathionylating species in vivo.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: